HIGHLIGHTS
- who: Lukas John from the Medical University of Lodz, Poland have published the paper: Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma, in the Journal: (JOURNAL)
- what: This is an open-access article use distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited in accordance with accepted academic practice. The aim of this prospective cohort study was to prospectively examine the distribution of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.